Pump therapy at a price you can afford.
Pay around $49†/month depending on insurance coverage.
For a simple monthly payment, the Flex program offers a package which includes a Medtronic insulin pump, transmitter, infusion sets, and reservoirs.
Call today to learn more about your monthly cost to start using the Medtronic insulin pump therapy!
How does Flex work?
If you choose to take part in Flex, we will split up your out-of-pocket costs into monthly payments.
Step 1: Order a new insulin pump today
Step 2: We will ship you the insulin pump and a starter kit so you can begin therapy
Step 3: Make a monthly payment and enjoy the latest technology from Medtronic
Technology that adapts to you:
MiniMed™ 780G system
The only system with Meal Detection technology™‡ that provides automatic adjustments and corrections§ to sugar levels every 5 minutes.Ω
The system connects directly with a smart device, allowing you to view sugar trends and insulin data on the go!
MiniMed™ 630G system
The MiniMed™ 630G system uses SmartGuard™ technology and lets you know up to 30 minutes ahead if you’re trending high or low, so you can act sooner to keep your glucose levels where you want them.
The optional CGM sends information to your pump every five minutes, so you can see how you’re doing, spot trends and make adjustments!
What would be my monthly payment?
The amount you will pay with Flex is calculated by dividing your total out-of-pocket responsibility by 48 and adding the $6 service fee. Your total coinsurance amount is dependent on your insurance coverage.
What is included with Flex?
Flex payments cover your out-of-pocket cost for a Medtronic insulin pump and starter kit. The starter kit includes transmitter and a 3-month supply of the following items: sensors, infusion sets, and reservoirs.
Flex payments do not include ongoing supplies beyond (or after) the first 90 days. To continue using pump therapy, you must purchase additional transmitters, sensors, infusion sets, and reservoirs separately.
Call us at 800-646-4633 Option 3 between the hours of 9AM - 6PM CST or complete the form to receive a call from us.
Frequently Asked Questions
- Out-of-warranty Medtronic customers
- Out-of-warranty customers using another pump brand
- Customers who are new to pump therapy
Distributor patients are not eligible for this program.
Online: ACH Payment, Credit Card
† $49/month estimate is calculated based on average out-of-pocket cost paid over 48 months. Monthly payments include a $6/month service fee. Final cost may be higher or lower than $49/month depending on individual insurance.
‡Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
§ Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
Ω Refers to SmartGuard™ feature. Individual results may vary.
- $49/month estimate is calculated based on average out-of-pocket cost paid over 48 months.
- Monthly payments include a $6/month service fee.
- Final cost may be higher or lower than $49/month depending on individual insurance.
- Patient may elect to pay a portion or all of the upfront cost at any time, without penalty.
- Starter kit includes one (1) transmitter and a 90-day supply of sensors, infusion sets, and reservoirs associated with your insulin pump.
- Monthly payments for Flex do not include ongoing supplies except for the first 90 days. To continue using pump therapy, patients must purchase additional transmitters, sensors, infusion sets, and reservoirs separately.
- No upfront payment is required and first month payment will begin 30-60 days after pump shipment. Individual payment timelines may vary.
- MiniMed™ pumps have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider.
- A valid prescription will be required to purchase. Other restrictions may apply.
- Program terms are subject to change at any time and without notice.
The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G insulin pump, the Guardian™ 4 transmitter, the Guardian™ 4 sensor, One-press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide test strips. The system requires a prescription from a healthcare professional.
The Guardian™ 4 sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ 4 sensor is indicated for up to seven days of continuous use.
The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.
WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.
WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library
Important Safety Information: MiniMed™ 630G System with SmartGuard™ Technology
Indicated for the continuous delivery of insulin, at set and variable rates, for the management of diabetes mellitus. MiniMed™ 630G system is approved for ages 14 years or older with Guardian™ Sensor 3 and MiniMed™ 630G system is approved for ages 16 years or older with Enlite™ sensor. Both systems require a prescription. Insulin infusion pumps and associated components of insulin infusion systems are limited to sale by or on the order of a physician and should only be used under the direction of a healthcare professional familiar with the risks of insulin pump therapy. Pump therapy is not recommended for people who are unwilling or unable to perform a minimum of four blood glucose tests per day. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Insulin pumps use rapid-acting insulin. If your insulin delivery is interrupted for any reason, you must be prepared to replace the missed insulin immediately. Replace the infusion set every 48–72 hours, or more frequently per your healthcare professional’s instructions. Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected. The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a blood glucose meter. A confirmatory fingerstick using a CONTOUR®NEXT LINK 2.4 meter is required prior to making adjustments to diabetes therapy. Always check the pump display when using a CONTOUR®NEXT LINK 2.4 meter, to ensure the glucose result shown agrees with the glucose results shown on the meter. Do not calibrate your CGM device or calculate a bolus using a result taken from an Alternative Site (palm) or a result from a control solution test. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. The MiniMed™ 630G system is not intended to be used directly for preventing or treating hypoglycemia but to suspend insulin delivery when the user is unable to respond to the Suspend on low alarm and take measures to prevent or treat hypoglycemia themselves. Therapy to prevent or treat hypoglycemia should be administered according to the recommendations of the user’s healthcare provider.
WARNING: The SmartGuard™ Suspend on low feature will cause the pump to temporarily suspend insulin delivery for two hours when the sensor glucose reaches a set threshold. Under some conditions of use the pump can suspend again, resulting in very limited insulin delivery. Prolonged suspension can increase the risk of serious hyperglycemia, ketosis, and ketoacidosis. Before using the SmartGuard™ feature, it is important to read the SmartGuard™ feature information in the User Guide and discuss proper use of the feature with your healthcare provider.
See important safety information and the appropriate user guides for additional important details.
Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected. Please visit important safety information for more details.
The CONTOUR®NEXT LINK 2.4 Meter is used with the MiniMed™ 630G system.